TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Similarly, the TM6SF2 variant (rs58542926) reduces very low-density lipoprotein (VLDL) secretion, resulting in fat retention within the liver and promoting NAFLD progression [57,58].